Two Sigma Investments »

Casi Pharmaceuticals shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Casi Pharmaceuticals (CASI) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Casi Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Casi Pharmaceuticals held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Casi Pharmaceuticals by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $55k 33k 1.66

More positions owned by Two Sigma Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr Financial (XLF)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Core S&p500 Etf (IVV)
Rivian Automotive Com Cl A (RIVN)
Palantir Technologies Cl A (PLTR)
NVIDIA Corporation (NVDA)
Micron Technology (MU)
Lockheed Martin Corporation (LMT)
Ishares Tr Rus 1000 Grw Etf (IWF)
Microsoft Corporation (MSFT)
Alnylam Pharmaceuticals (ALNY)

View all positions for Two Sigma Investments

Top funds holding Casi Pharmaceuticals

VR Adviser
Foresite Capital Management VI
Woodline Partners
Wellington Shields Capital Management
Renaissance Technologies
Two Sigma Investments
Wellington Shields & Co
Geode Capital Management
Ground Swell Capital
Royal Bank of Canada
Group One Trading
Wells Fargo & Company
Morgan Stanley
BlackRock
Simplex Trading

View all funds holding Casi Pharmaceuticals